Pseudo‐Bartter syndrome in children with cystic fibrosis
Abstract Cystic fibrosis (CF) is an autosomal recessive genetic disorder. We report a case of a boy aged 4.5 years with cystic fibrosis,...
Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 fo
NEW YORK and CLEVELAND, April 30, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and...
We Must Pay Closer Attention to the Global CF Population
Based on the stringent qualifications the Cystic Fibrosis Foundation uses to determine who has cystic fibrosis, approximately 70,000...
How Organ Transplant Works
The misconception that all patients in need of organ donation are responsible for their ill health should not suffice. Of course, there...
Common virus could speed up cystic fibrosis
A new study has found that cytomegalovirus, which is normally dormant in people who have it, can become active again in people with...
Cytomegalovirus – an unrecognised potential contributor to cystic fibrosis disease progression?
Given increasing body of work supporting an association of cytomegalovirus (CMV) seropositivity with several chronic medical conditions,...
The Future of Cell and Gene Therapy
Each passing year, the success of cell and gene therapy (CGT) becomes clearer, more widely covered in the media, and is increasingly the...
Choline Supplementation Improves Lung Function, Liver Health in CF Patients, Study Shows
Choline supplementation improves lung function and liver health in people with cystic fibrosis (CF), and should be considered as a...
Mucus and Inflammation, Rather Than Infections, are Early Drivers of Lung Disease in CF, Study Says
Early accumulation of abnormally thick mucus and inflammation in the lungs, rather than bacterial infections, may be the initial trigger...
Positive Expiratory Pressure (PEP)
Cystic fibrosis (CF) is a genetic condition caused by abnormalities in the function of the cystic fibrosis transmembrane regulator (CFTR)...
